AU2001267239A1 - Viral phospholipase a2 enzymes, anti-viral agents and methods of use - Google Patents
Viral phospholipase a2 enzymes, anti-viral agents and methods of useInfo
- Publication number
- AU2001267239A1 AU2001267239A1 AU2001267239A AU6723901A AU2001267239A1 AU 2001267239 A1 AU2001267239 A1 AU 2001267239A1 AU 2001267239 A AU2001267239 A AU 2001267239A AU 6723901 A AU6723901 A AU 6723901A AU 2001267239 A1 AU2001267239 A1 AU 2001267239A1
- Authority
- AU
- Australia
- Prior art keywords
- viral
- enzymes
- methods
- phospholipase
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010058864 Phospholipases A2 Proteins 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2310263 | 2000-06-28 | ||
CA2310263 | 2000-06-28 | ||
PCT/CA2001/000932 WO2002000924A2 (en) | 2000-06-28 | 2001-06-28 | Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001267239A1 true AU2001267239A1 (en) | 2002-01-08 |
Family
ID=4166336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001267239A Abandoned AU2001267239A1 (en) | 2000-06-28 | 2001-06-28 | Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001267239A1 (en) |
WO (1) | WO2002000924A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002323520B2 (en) | 2001-08-31 | 2008-02-21 | Gen-Probe Incorporated | Assay for detection of human parvovirus B19 nucleic acid |
WO2008037123A1 (en) * | 2006-09-29 | 2008-04-03 | Green Life Laboratory Limited | Recombinant periplaneta fuliginosa densovirus and use thereof |
US11718834B2 (en) | 2019-02-15 | 2023-08-08 | Sangamo Therapeutics, Inc. | Compositions and methods for producing recombinant AAV |
CN110819737A (en) * | 2019-09-02 | 2020-02-21 | 深圳芭卡生物科技有限公司 | Primer and kit for detecting cat intestinal infection pathogens and application of primer and kit |
CN112322791B (en) * | 2020-11-27 | 2023-10-27 | 福建省农业科学院畜牧兽医研究所 | Novel duck dependent genus virus loop-mediated isothermal amplification detection primer set and kit |
CN112852749A (en) * | 2021-03-27 | 2021-05-28 | 哈尔滨元亨生物药业有限公司 | Hybridoma cell strain C68 capable of efficiently secreting canine parvovirus monoclonal antibody and production method thereof by using bioreactor |
CN114716567B (en) * | 2022-03-01 | 2024-08-09 | 上海赛伦生物技术股份有限公司 | Preparation method and application of chimeric antigen and preparation for resisting bungarose venom |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2340230T3 (en) * | 1998-11-10 | 2010-05-31 | University Of North Carolina At Chapel Hill | VIRIC VECTORS AND THEIR PREPARATION AND ADMINISTRATION PROCEDURES. |
-
2001
- 2001-06-28 AU AU2001267239A patent/AU2001267239A1/en not_active Abandoned
- 2001-06-28 WO PCT/CA2001/000932 patent/WO2002000924A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002000924A3 (en) | 2002-04-11 |
WO2002000924A2 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001283492A1 (en) | Methods of patterning protein and cell adhesivity | |
AU2001267475A1 (en) | Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof | |
AU2001267333A1 (en) | Lipolytic enzyme | |
AU2002210450A1 (en) | Maintaining virus detection software | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU6111000A (en) | Inhibitors of viral helcase | |
AU7078100A (en) | Methods of identifying anti-viral agents | |
AU2002231206A1 (en) | Treatment of depression | |
AU2001288972A1 (en) | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU2001268701A1 (en) | Methods of enhancing adhesion | |
AU2001267239A1 (en) | Viral phospholipase a2 enzymes, anti-viral agents and methods of use | |
AU2000239273A1 (en) | Systems and methods of viral marketing | |
AU2000275763A1 (en) | Expression of functional eukaryotic proteins | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU2001237592A1 (en) | Enzymes and uses relating thereto | |
AU7740100A (en) | Efficient implementation of multiprecision arithmetic | |
AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
AU2001280198A1 (en) | Airway-specific trypsin-like enzymes and method of using the same | |
AUPQ599500A0 (en) | Novel peptides, modulatory agents therefor and methods of using them | |
AU2001285392A1 (en) | Macromolecular enzyme substrates | |
AU2001264856A1 (en) | Inhibitors of viral infection | |
AU2002250842A1 (en) | DNA sequence of the enzyme phospholipase A1 of ciliate tetrahymena, and the use of the same | |
AU2001254670A1 (en) | Detection of hepatitis b virus rna |